Yüklüyor......
Subcutaneous Administration of Bortezomib in Combination with Thalidomide and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma Patients
Objective. To investigate the efficacy and safety of the treatment of the newly diagnosed multiple myeloma (MM) patients with the therapy of subcutaneous (subQ) administration of bortezomib and dexamethasone plus thalidomide (VTD) regimen. Methods. A total of 60 newly diagnosed MM patients were anal...
Kaydedildi:
| Yayımlandı: | Biomed Res Int |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Hindawi Publishing Corporation
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4575715/ https://ncbi.nlm.nih.gov/pubmed/26425561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/927105 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|